Cited by 951Probiotics and Fermented FoodsDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index; none of the 44 sources its claims cite is checked for support yet.

Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial

Open access

Akbari, Elmira, Asemi, Zatollah, Daneshvar Kakhaki, Reza, Bahmani, Fereshteh, Kouchaki, Ebrahim, Tamtaji, Omid Reza, Hamidi, Gholam Ali, Salami, Mahmoud·2016·Frontiers in Aging Neuroscience

DOI 10.3389/fnagi.2016.00256PMC PMC5105117

Open this paper in CoChat — free account Open PDF

Abstract

Alzheimer's disease (AD) is associated with severe cognitive impairments as well as some metabolic defects. Scant studies in animal models indicate a link between probiotics and cognitive function. This randomized, double-blind and controlled clinical trial was conducted among 60 AD patients to assess the effects of probiotic supplementation on cognitive function and metabolic status. The patients were randomly divided into two groups (n=30 in each group) treating with either milk (control group) or a mixture of probiotic (probiotic group). The probiotic supplemented group took 200 ml/day probiotic milk containing Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum and Lactobacillus fermentum (2×109 CFU/g for each) for 12 weeks. Mini-mental state examination (MMSE) score was recorded in all subjects before and after the treatment. Pre- and post-treatment fasting blood samples were obtained to determine the related markers. After 12 weeks intervention, compared with the control group (-5.03%±3.00), the probiotic treated (+27.90%±8.07) patients showed a significant improvement in the MMSE score (P<0.001). In addition, changes in plasma malondialdehyde (-22.01%±4.84 vs. +2.67%±3.86 µmol/L, P<0.001), serum high-sensitivity C-reactive protein (-17.61%±3.70 vs. +45.26%±3.50 µg/mL, P<0.001), homeostasis model of assessment-estimated insulin resistance (+28.84%±13.34 vs.+76.95%±24.60, P=0.002), Beta cell function (+3.45%±10.91 vs. +75.62%±23.18, P=0.001), serum triglycerides (-20.29%±4.49 vs. -0.16%±5.24 mg/dL, P=0.003) and quantitative insulin sensitivity check index (-1.83±1.26 vs. -4.66±1.70, P=0.006) in the probiotic group were significantly varied compared to the control group. We found that the probiotic treatment had no considerable effect on other biomarkers of oxidative stress and inflammation, fasting plasma glucose and other lipid profiles. Overall, the current study demonstrated that probiotic consumption for 12 weeks positively affects cognitive function and some metabolic statuses in the AD patients.

AI snapshot

Written from the paper’s full text.

TL;DR

In a 12-week randomized, double-blind controlled trial of 60 Alzheimer’s disease patients, probiotic milk supplementation improved MMSE scores and some metabolic/inflammatory markers compared with control milk. The authors conclude probiotics may have favorable effects on cognition and selected metabolic statuses in AD, but not on all oxidative stress, inflammation, glucose, or lipid measures.

Key findings

MMSE score improved in the probiotic group (+27.90% ± 8.07) versus worsening in the control group (−5.03% ± 3.00; P < 0.001).
Probiotic treatment significantly changed plasma MDA (−22.01% ± 4.84 vs. +2.67% ± 3.86 μmol/L, P < 0.001), serum hs-CRP (−17.61% ± 3.70 vs. +45.26% ± 3.50 μg/mL, P < 0.001), HOMA-IR (+28.84% ± 13.34 vs. +76.95% ± 24.60, P = 0.002), HOMA-B (+3.45% ± 10.91 vs. +75.62% ± 23.18, P = 0.001), serum triglycerides (−20.29% ± 4.49 vs. −0.16% ± 5.24 mg/dL, P = 0.003), and QUICKI (−1.83 ± 1.26 vs. −4.66 ± 1.70, P = 0.006).
No considerable effect was found on other oxidative stress and inflammation biomarkers, fasting plasma glucose, or other lipid profiles (LDL, HDL, total cholesterol).
No side effects were reported following probiotic administration.

Methods

Randomized, double-blind, controlled 12-week clinical trial in 60 AD patients aged 60–95 years residing at welfare organizations in Kashan and Esfahan, Iran; participants were randomized to control milk (n = 30) or probiotic milk (n = 30), matched at baseline for disease severity based on gender, BMI, and age.
Probiotic group received 200 ml/day milk containing Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum, and Lactobacillus fermentum (2 × 10^9 CFU/g for each) for 12 weeks; control group received milk.
Primary outcome was MMSE; secondary outcomes included oxidative stress, inflammation, and metabolic biomarkers from fasting blood samples at weeks 0 and 12. Analyses used intention-to-treat with LOCF for missing values, independent t-tests, and ANCOVA adjustment for baseline biochemical values, age, and BMI.

Limitations

The paper states that measuring fecal bacteria loads before and after probiotic supplementation in AD patients was very difficult.
The paper states that cognition was assessed only with the MMSE, and that other cognitive criteria and additional inflammatory/oxidative biomarkers such as IL-6, TNF-α, catalase, and SOD would be informative.
Evident from the text: the sample was small (60 randomized; 52 completed), with deaths/dropouts during the study, and baseline serum triglycerides, VLDL, and HDL differed significantly between groups, although the authors report adjustment did not considerably change findings.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fnagi.2016.00256

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 44 cited sources checked · 0 supported · 0 flagged

A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Findings of the current study indicated that while the probiotic supplementation decreased the plasma MDA and the serum hs-CRP levels it was ineffective on other biomarkers of oxidative stress and inflammation.”
- Also stated in: § Discussion · boosted
  “Overall, the current study demonstrated that 12 weeks consumption of probiotic in the AD patients had favorable effects on MDA, hs-CRP, markers of insulin metabolism, and serum levels of triglyceride and VLDL.”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
Load-bearingStrength:boosted· not yet calibratedCausal:direct· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Findings of the current study indicated that while the probiotic supplementation decreased the plasma MDA and the serum hs-CRP levels it was ineffective on other biomarkers of oxidative stress and inflammation.”
- Also stated in: § Discussion · plain
  “However, the pobiotic treatment was inefective on other biomarkers of oxidative stress and inflammation, FPG, and other lipid profiles.”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
Strength:plain· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes

Show all 27 claims

It may state two separate claims as one. 23
Probably not a substantial claim. 35

In the paper
“The MMSE was used to assess cognition in the AD subjects (Folstein et al., 1975).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Materials and methods > Assessment of outcomes
What the sources say
- Not checked yetcites Folstein et al., 1975 source
Load-bearingStrength:plain· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
Probably not a substantial claim.
In the paper
“In our previous work, we have shown that probiotics efficiently reverse the impaired spatial learning and memory as well as synaptic transmission in diabetes mellitus (Davari et al., 2013).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Davari et al., 2013 source
Strength:boosted· not yet calibratedCausal:direct· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“It is demonstrated that other brain related disorders such as multiple sclerosis (Kouchaki et al., 2016) and stress are also influenced by probiotics (Liang et al., 2015).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Kouchaki et al., 2016 source
- Not checked yetcites Liang et al., 2015 source
Strength:boosted· not yet calibratedCausal:direct· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Increased biomarkers of oxidative stress (Furman et al., 2016), inflammation and chronic neuroinflammation are reported to be associated with many neurodegenerative disorders of central nervous system (CNS) including AD (Leszek et al., 2016).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Background
What the sources say
- Not checked yetcites Furman et al., 2016 source
- Not checked yetcites Leszek et al., 2016 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Gareau reported that intestinal dysbiosis in germ free animals (containing no microbiota), bacterial infection with an enteric pathogen and administration of probiotics can modulate cognitive behaviors including learning and memory (Gareau, 2014).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Background
What the sources say
- Not checked yetcites Gareau, 2014 source
Load-bearingStrength:plain· not yet calibratedCausal:direct· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“AD patients are predisposed to some complications including increased oxidative stress (Sultana et al., 2011), morbidity, mortality (Schelke et al., 2016), microvascular disease, dyslipidemia, and insulin resistance (Sridhar et al., 2015).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Sultana et al., 2011 source
- Not checked yetcites Schelke et al., 2016 source
- Not checked yetcites Sridhar et al., 2015 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Missing values were treated based on Last-Observation-Carried-Forward method (LOCF) (Lachin, 2016).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Materials and methods > Statistical methods
What the sources say
- Not checked yetcites Lachin, 2016 source
Strength:plain· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Probiotics intake may improve markers of insulin metabolism and lipid profiles by reducing cytokines and suppressing the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway (Shi et al., 2006) and gut microbiota-short chain fatty acids (SCFA)-hormone axis (Yadav et al., 2013).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Shi et al., 2006 source
- Not checked yetcites Yadav et al., 2013 source
Load-bearingStrength:hedged· not yet calibratedCausal:conditional· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
It may state two separate claims as one.
In the paper
“Consumption of symbiotic bread containing the heat-resistant probiotic Lactobacillus sporogenes (1 × 108 CFU/g) for 8 weeks also decreased the serum triglyceride and VLDL concentrations in patients with type 2 diabetes (Shakeri et al., 2014).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Shakeri et al., 2014 source
Strength:plain· not yet calibratedCausal:direct· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Accordingly, high lipid levels could be one of the risk factors for AD (Reitz et al., 2010).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Reitz et al., 2010 source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Oxidative stress is a frequently observed feature of AD, although its pathological significance is not understood (Selvarajah et al., 2011).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Selvarajah et al., 2011 source
Strength:plain· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Evidence indicates that, through production of reactive oxygen species, oxidative stress acts as vehicle for deposition and accumulation of amyloid β (Aβ) in AD (Kim et al., 2015).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Kim et al., 2015 source
Strength:hedged· not yet calibratedCausal:direct· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“For example, it was reported that 6 weeks probiotic treatment caused no significant change in inflammatory factors of diabetic patients (Mazloom et al., 2013).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Mazloom et al., 2013
Strength:plain· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Dysfunctions in GABA-signaling are linked to anxiety and depression, defects in synaptogenesis and cognitive impairments (Aziz et al., 2013; Mitew et al., 2013).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Aziz et al., 2013 source
- Not checked yetcites Mitew et al., 2013 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes
It may state two separate claims as one.
In the paper
“Also the glutamatergic NMDA receptors are involved in the most important excitatory neurotransmission of brain (Talaei et al., 2016) which is engaged in the neural circuits involved in learning and memory.”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Talaei et al., 2016 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Furthermore, 8 weeks consumption of capsules containing 108 CFU/g of L. casei by the people suffered from rheumatoid arthritis displayed no significant within- and between-group changes in MDA and TAC levels (Vaghef-Mehrabany et al., 2015).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Vaghef-Mehrabany et al., 2015 source
Strength:plain· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In addition, Zarrati et al. (2014) showed that 8 weeks consumption of yogurt, enriched by L. acidophilus, Bifidobacterium langum, and L. casei (108 CFU/g each) decreased inflammatory cytokines in overweight people.”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Zarrati et al., 2014 source
Strength:plain· not yet calibratedCausal:direct· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Some evidence from clinical studies support the fact that abnormal cholesterol metabolism in the brain leads to progressive cognitive dysfunction (Wang et al., 2014).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Wang et al., 2014 source
Strength:hedged· not yet calibratedCausal:direct· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Further, findings from germ free animals indicated a decreased level of brain derived neurotrophic factor (BDNF), important neurotrophic factor in the neuronal growth and survival, and a reduced expression of some subunits of N-Methyl-D-aspartate (NMDA) receptors (Sudo et al., 2004) involved in most abundant neurotransmission in brain (Salami et al., 2000).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Sudo et al., 2004 source
- Not checked yetcites Salami et al., 2000 source
Load-bearingStrength:hedged· not yet calibratedCausal:direct· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
It may state two separate claims as one.
In the paper
“Emerging evidence has demonstrated that brain insulin resistance, as a key mediator in prediabetes and diabetes mellitus, may take a role in AD (Cervellati et al., 2016).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Cervellati et al., 2016 source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“It has also been postulated that oxidative stress may decrease the activity of α-secretase, which promotes the expression and activity of β and γ-secretase, leading to the increased production of Aβ (Tan et al., 2013).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Tan et al., 2013 source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Insulin resistance plays an important role in the development of cognitive impairment in primary elderly hypertensive patients (Ma et al., 2015).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Ma et al., 2015
Strength:plain· not yet calibratedCausal:direct· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Consistently, in a meta-analysis study, Kasińska and Drzewoski (2015) reported a reduced HOMA-IR and insignificant FGP in probiotic treated subjects.”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Kasińska and Drzewoski, 2015
Strength:plain· not yet calibratedCausal:direct· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Consistent to our findings, a significant reduction in MDA levels was reported in type 2 diabetic patients after consuming probiotic yogurt (Ejtahed et al., 2012).”
§ Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial > Discussion
What the sources say
- Not checked yetcites Ejtahed et al., 2012 source
Strength:plain· not yet calibratedCausal:direct· not yet calibrated
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passes
Probably not a substantial claim. The paper’s conclusions may not depend on it.

50 of 50

The paper relies on this without support.
No direct study has considered gut microbiota manipulation in Alzheimer's disease patients.
“However, no direct study has considered the gut microbiota manipulation in AD patients.”
The paper relies on this without support.
Studies considering the effect of probiotic supplements on brain behavioral phenomena are scant.
“Studies considering the effect of probiotic supplements on brain behavioral phenomena are scant.”
The paper relies on this without support.
This study is the first to evaluate the beneficial effects of probiotic supplementation on cognitive function, biomarkers of oxidative stress, inflammation, and metabolic status in patients with Alzheimer's disease.
“To the best of our knowledge, this study is the first evaluating the beneficial effects of probiotic supplementation on cognitive function, biomarkers of oxidative stress, inflammation and metabolic status in patients with AD.”
The paper relies on this without support.
The probiotic intervention changed the gut microbiota in the AD patients.
“Measurement of fecal bacteria loads before and after the probiotic supplementation in the AD patients was very difficult.”

4 of 4

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 retracted

RETRACTED: Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial
Kouchaki, E., Tamtaji, O. R., Salami, M., Bahmani, F., Daneshvar Kakhaki, R., Akbari, E., Tajabadi-Ebrahimi, M., Jafari, P., & Asemi, Z. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.08.015 · Cited by 317 · cited 1×
“It is demonstrated that other brain related disorders such as multiple sclerosis (Kouchaki et al., 2016) and stress are also influenced by probiotics (Liang et al., 2015).”
BackgroundSelf-citation
Retracted
RETRACTED ARTICLE: The effects of probiotics on mental health and hypothalamic–pituitary–adrenal axis: A randomized, double-blind, placebo-controlled trial in petrochemical workers
Mohammadi, A. A., Jazayeri, S., Khosravi‐Darani, K., Solati, Z., Mohammadpour, N., Asemi, Z., Adab, Z., Djalali, M., Tehrani‐Doost, M., Hosseini, M., et al. (2015) · Nutritional Neuroscience · doi:10.1179/1476830515y.0000000023 · Cited by 241
Self-citation
Retracted
“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · cited 2×
“It is generally agreed that probiotic strains should be of host origin with a beneficial effect on the host, withstand into food stuff with a high count, withstand transits through intestine and colonize lumen of the tract, produce antimicrobial agents, and technologically appropriate for…”
BackgroundMethod
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay
Benzie, I. F. F., & Strain, J. (1996) · Analytical Biochemistry · doi:10.1006/abio.1996.0292 · Cited by 23,027 · cited 1×
“Plasma total antioxidant capacity (TAC) was measured using the ferric reducing antioxidant power method developed by Benzie and Strain (1996).”
Method
[Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572 · cited 2×
“The difference between the two groups of testing was statistically significant (P < 0.001).”
BackgroundInfluential

Flagged first, then by citations

Show all 60 references

1 of the 60 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Shewale, 2014, Selection criteria for probiotics: a review, Int. J. Probiotics Prebiotics, 9, 17

Sorted by citations

Items 901–951 of 951

Cognitive dysfunction resulting in telomere degradation: the potential of probiotics as a supplement
Sekar, J. M., Prabhu, V., Subramanian, P., Nehru, M., & Subbiah, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27622-4.00002-x
Development and Genomic Evaluation of a Novel Functional Fermented Milk Formulated with Lactobacillus delbrueckii Strains and Jujuba Kernel Powder for Potential Neuroprotective Effects
Ibrahim, A., Halfawy, N. E., Zhang, Y., Liu, Y., Zhang, X., Zhou, S., Kan, J., & Du, M. (2025) · Foods · doi:10.3390/foods14244264
THE GUT-BRAIN AXIS IN NEURODEGENERATIVE DISEASES AND MOOD DISORDERS: MECHANISMS AND SCIENTIFIC EVIDENCE
Przerwa, J. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(48).2025.4431 · Cited by 1
Microbiota and Alzheimer's disease: Toward new clinical approaches
Đokić, J., & Dinić, M. (2025) · Medicinski podmladak · doi:10.5937/mp76-60520 · Cited by 1
Chronic stress, gut dysbiosis, and cholesterol metabolism: Implications for Alzheimer's disease
Das, A., Navya, P., Chowdhury, D., Das, A., Manna, R., & Bodakhe, S. H. (2026) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2026.578853
Systemic Amyloid-β Metabolism in Alzheimer’s Disease
Dong-yu, F., Wang, J., Gu, B. J., Masters, C. L., & Wang, Y. (2026) · Springer eBooks · doi:10.1007/978-981-95-5222-1_7
Food, psychobiotics and their role in mental health
Kumar, T., Bansal, U., Singh, S., & Sharma, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33116-9.00014-0
Exploring Bifidobacteria-Fermented Dairy Products: Innovations, Challenges, and Health-Related Insights
Hang, G., Guo, Y., & Li, W. (2026) · Current Microbiology · doi:10.1007/s00284-026-04784-7 · Cited by 1
Engineered bacteria: a novel era for metabolic, cardiovascular and cerebrovascular diseases therapy
Wu, Y., Sang, R., Chen, X., & Wang, S. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1757348
“Several experiments have demonstrated that a variety of Biﬁdobacterium and Lactobacillus species can ameliorate the pathology of AD (60, 61), and the positive effects of Biﬁdobacterium and Lactobacillus on PD have been similarly demonstrated from in vitro experiments in L. Magistrelli’s experiments…”
The pathogenic role of gut microbiota dysbiosis in Alzheimer’s disease: a narrative review of neuroimaging evidence
Hesarooeyeh, Z. G., Khalili, E., Michel, T., & Vafaee, M. S. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-026-03126-y
“However, clinical findings remain inconsistent and highly strain-specific, limiting their current translational applicability (Akbari et al. 2016; Suez et al. 2019 ).”
Systematic review of probiotic supplementation in Alzheimer’s patients with results on cognitive function, health biomarkers, and microbiota
Fernández‐Lázaro, D., Miguel, A. M., Araque, A. F., Olmedo, B. V., Santamaría, G., & Mielgo‐Ayuso, J. (2026) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2026.1004140
Impact d'une supplémentation en actifs d'origine marine sur la neuroinflammation associée au déclin cognitif lié à l'âge
Chataigner, M. (2021) · theses.fr (ABES) · doi:10.70675/a4317690zc4c8z4ba6za738zd457c6bb9b74
Peptidoglycan : a key elicitor of the gut- brain axis
Fioriti, F. (2023) · theses.fr (ABES) · doi:10.70675/9e7ce0aaz9b66z467bzbc3fz6fa3bf65d9a6
Alzheimer Hastalığı Ve Bağırsak Mikrobiyotası İle İlgili Çalışmaların Bibliyometrik Analizi
BAŞÇIL, S. G. (2026) · Muş Alparslan Üniversitesi Sağlık Bilimleri Dergisi · doi:10.71255/maunsbd.1796293
Gut Microbiota, Probiotics, and Aging: Molecular Mechanisms and Implications for Healthy Aging (Russian Translation)
Kim, J.-Y. (2026) · Juvenis scientia · doi:10.32415/jscientia_2026_12_1_38-55
Therapeutic Interventions: Modulating the Microbiome to Combat Neurodegeneration
Anandan, A., Unais, A. M., Prabhu, A. V., Saju, M. K., Sonaimuthu, K., Murugesan, H., Danielraj, F., Marimuthu, D., Shibu, M. A., & Viswanadha, V. P. (2026) · Springer eBooks · doi:10.1007/978-981-95-7494-0_8
Intestinal microbiota in neurodegeneration and ageing: Mechanisms, pathways, and therapeutic interventions
Khodve, G., Raval, S., & Banerjee, S. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.05.015
Gerobiotics and neuroprotection: effects on the gut-brain axis in age-related neurodegenerative diseases
Bozkurt, B. K., Aslan, S., Bozkurt, O., Bodur, M., Ağagündüz, D., & Budán, F. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1814234
Oral microbiota dysbiosis and the oral-X axis in chronic diseases
Li, E., Huang, J., Yao, J., Lei, M., & Wu, M. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102274
Relationship between gut microbiota and neurodegenerative diseases: A scientometric visualization analysis (2005–2024) analysis
wang, S., lin, X., Sun, Z., Cui, S., & Fang, X. (2026) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2026.109166
Probiotics and the Gut Microbiome in Combat Sports: A Narrative Review of Performance, Recovery, and Health Pathways
Hemmatinafar, M., Tajanaki, A. S., Jäger, R., & Safari, K. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11087-7
Gut microbiota as a drug discovery target: Mechanistic insights and therapeutic potential
Mondal, S., Chowdhury, S., Kar, K., Mazumder, K., & Chakraborty, P. (2026) · Gut Microbiome and Health · doi:10.1016/j.gmh.2026.100002
Structural characteristics of Acanthopanax Senticosus polysaccharides and their improvement of cognitive impairment in mice
Jiang, Y., Liu, S., Liu, X., Tang, W., Sun, B., Wang, Y., Li, X. Q., & Zhao, H. (2026) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2026.103086
Targeting microbiota–gut–brain axis with phytochemicals: a mechanistic roadmap for dementia
Manna, P., Ganguly, S. C., Chatterjee, A., Mondal, B., Maity, A., Chatterjee, S., Guria, T., & Chakraborty, M. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01909-6
“Probiotic treatments for Alzheimer’s disease (AD) have pro - duced encouraging outcomes (Akbari et al. 2016).”
Opposite regulatory effects of Blautia massiliensis and Blautia faecis on cognitive function, microglia and metabolite acetic acid in mice
Li, M. M., Wu, N., Yu, W., Wang, X., Zhao, Y., Ge, X., Zhao, Z., Wang, X., & Guo, J. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1854107
Comparative efficacy and safety of pathway-targeted pharmacotherapies for Alzheimer’s disease: A systematic review and network meta-analysis of phase III trials
Wu, Y., Di, Y., Wang, H. W., Wang, L., Zhang, J., Zhang, Y., & Lyu, D. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103216
The interplay between gut microbiota and Alzheimer’s disease: mechanistic insights from dysbiosis to disease modulation
Das, K., Khatun, R., Begum, S., Bhattacharyya, K., Datta, M., Saha, D., Sarma, A., Mehta, P., & Das, B. K. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01922-9
Effect of Probiotic Supplementation in Older Individuals with Mild Cognitive Impairment and Alzheimer’s Disease: A Randomized, Placebo-Controlled, Triple-Blind Clinical Trial
Medeiros, E. B., Monteiro, I. D. O., Kluwe‐Schiavon, B., Possamai, O. L., Fenilli, G. P., Keller, G. S., Lídio, A. V., Casagrande, D. D., Souza, C. S. M., Silveira, G. D. B., et al. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11104-9
Gut Microbiota in Alzheimer′s Disease: Mechanisms, Evidence, and Therapeutic Implications
Ramya, D. M., & Harshitha, B. (2026) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/4510434
Oral Microbiota, the Oral–Brain Axis, and Neurodegeneration: Mechanisms and Dietary Modulation
Godos, J., Caruso, G., Mainas, G., Micek, A., Mauro, A. D., Buccarello, L., López, N. M. M., Frías-Toral, E., Giampieri, F., Lehoczki, A., et al. (2026) · Antioxidants · doi:10.3390/antiox15080925
“…supplementation (including L. acidophilus , L. casei , L. fermentum and B. bifidum ) significantly improved Mini-Mental State Examination (MMSE) scores, reduced serum markers of oxidative stress (malondialdehyde), and decreased inflammatory biomarkers (high-sensitivity C-reactive protein) [92].”
Probiotics and Plant Extracts in the Gut–Brain Axis: Mechanisms, Interactions, and Clinical Perspectives
Sattar, Z., & Asili, J. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11152-1
The microbiota–gut–brain axis in neuropsychiatric disorders: Mechanisms, advances, and clinical applications
Li, T., Chang, Y., Tang, S., Chen, Y., Li, X., & Wang, Y. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.112062
Nutritional Characteristics of Edible Canna Leaves before and after Lactic Acid Fermentation and the Functionality of their 80% Methanol Extracts In Vitro
NARUKAWA, T., Takemoto, K., Iji, M., Miura, Y., Nishiuchi, A., TSUZUKI, M., Tetsu, Y. A. N. O., TAKAHASHI, H., Sato, T., & Watanabe, H. (2024) · food preservation science · doi:10.5891/jafps.50.161
Alzheimer’s Disease in the Era of Geroscience: Mechanisms, Biomarkers, and Therapeutic Prospects
Chmielewski, P. P. (2026) · Cells · doi:10.3390/cells15171599
“Probiotics and synbiotics have produced preliminary cognitive or metabolic findings in small trials, including a 12-week study in AD [118].”
Gut microbiota dysregulation in dementia: Molecular mechanism linking the gut-brain axis to neurodegeneration
Bhamare, J. S., Jha, P., Chintamaneni, M., & Kaur, G. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103373
Psychobiotics and the microbiota-gut-brain axis: A comprehensive review of mechanisms, efficacy, and translational challenges
Ahmed, A. M. F., Akhiljith, Balasubramanian, S., Afeeza, M., Nair, M., George, J., & Saraswathy, G. R. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.105119
Can live microbial interventions support healthy aging? A systematic review and meta-analysis of cognitive and muscle outcomes in aging adults
Silva-Olivares, F., Vidal-Herrera, N., Acevedo-Hernández, P., Rabbia, V., Petermann-Rocha, F. E., Thomas‐Valdés, S., & Jorquera, G. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1869929
An intestine-centric view of neurodegeneration: How intestine-derived signals mediate the intestine-brain axis to impact Alzheimer's disease
Shen, S., Zhou, Y., Qian, J., Li, T., Hu, X., Ji, X., Zhang, X., & Zhou, D. (2026) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2026.579102
Gut Microbiome-Mediated Neuroprotective Effect of the Mediterranean Diet: A Narrative Review of Cognitive Aging, Alzheimer’s Disease, and Parkinson’s Disease
Kamalakar, K., Akerele, C. A., Lafont, E., Koralnik, L. R., Gilman, C., Litran, J. C., Lee, J., Robinson‐Papp, J., & Malaspina, D. (2026) · Nutrients · doi:10.3390/nu18193146
“…with probiotic strains including Lactobacillus rhamnosus, Bifidobacterium breve MCC1274, and Bifidobacterium species, while animal studies have demonstrated reductions in amyloid-β deposition, neuroinflammation, oxidative stress, and improvements in memory and synaptic plasticity [131–136].”
Systematic review of probiotic dietary interventions for symptoms associated with dementia in older adults
Carrión, N., Cabrera, C., Heredia, L., & Torrente, M. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00334-w
“Although all included trials utilized ITT or FAS principles to attempt to preserve randomization, missing data were often managed using less robust methods, such as the LOCF method [23, 25, 28].”
Influential
New insight into Alzheimer’s disease: small molecule-Aβ in the brain transport and peripheral organ clearance
Tianci, M., Yongyi, L., Ding, Y., Liu, S., Gao, C., Li, X., Tong, Z., & Yan, L. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1921485
Gut microbiome modulation can improve cognitive function in older adults: a systematic review and meta-analysis
Birns, B., Murshed, S., & Lochlainn, M. N. (2026) · Age and Ageing · doi:10.1093/ageing/afag287
“Some studies in this review reported reduction of pro-inflammatory markers, such as interleukin-6 and faecal calprotectin, as well as improvements in insulin resistance and triglyceride levels [ 26, 29, 35].”
Influential
Bifidobacteria: From Gut Ecology to Health Effects in Foods
Medina-Rodriguez, E. M., Olivares, M., & Sanz, Y. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40344-6.00300-8
Rifaximin ameliorates memory impairment and Alzheimer's pathological changes in APP/PS1 mice associated with changes in the gut microbiome–bile acids–serum metabolites networks
Wu, D., Nie, M., Lin, J., Liu, Y., Wang, Y., Chu, M., Zheng, L., & Zhao, J. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70643
Unveiling mechanisms and potential application of probiotics in chronic inflammation and aging
Gan, R., Yu, Y., Duan, S., Fu, C., Wang, K., Han, H., & Li, M. D. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107543
Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies
Corbali, O., Menon, P., Corbali, H. I., Jagannathan, R., & Levey, A. I. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70487
“Probiotics RCTs (small size, AD) Meta-analysis of RCTs Mixed cognitive effects [230, 231] Increased BDNF levels in patients with neurological disorders [232] Intermittent fasting Small size RCTs (high BMI) Modest cognitive improvements reported [233, 234]; however, no large-scale studies have been…”
Immunosenescence as a modifiable driver of neurodegenerative diseases: Pathways and multidimensional emerging strategies for Alzheimer's and Parkinson's diseases
Zhao, J., Qu, L., 关宏锏, Che, H., Shi, F., & Yang, Y. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e01096
“It is unclear whether these effects translate into benefits for central immune aging in AD or PD [80].”
Neural correlates of cognitive enhancement after probiotic supplementationPreprint
Kim, S., Kang, S., Choi, Y. Y., Choi, K.-H., & Lee, K. H. (2026) · Research Square · doi:10.21203/rs.3.rs-11045321/v1
From gut microbiome to aging brain: Butyrate as a neurogeroscience effector
Mitrea, L., Calinoiu, L.-F., Martau, G.-A., Teleky, B.-E., Cocean, A.-M., Odocheanu, R., Stefanescu, B.-E., & Vodnar, D.-C. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.107037
Gut–brain axis in Alzheimer’s disease: neuroinflammatory mechanisms and immunopharmacological interventions
Sharma, R., Kumar, G., & Thakur, A. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02433-w
Microbiome-targeted strategies for Alzheimer’s disease: multi-omics signatures, mechanistic links, and intervention evidence
Huang, X., Zhang, X., & Qi, Z. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1828118

Authors: Akbari, E., Asemi, Z., Daneshvar Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O. R., Hamidi, G. A., & Salami, M.
Affiliations: Kashan University of Medical Sciences (IR)
Corresponding author: Asemi, Zatollah
Salami, Mahmoud
ORCID: Asemi, Zatollah
Bahmani, Fereshteh
Kouchaki, Ebrahim
Tamtaji, Omid Reza
Hamidi, Gholam Ali
Salami, Mahmoud
Venue: Frontiers in Aging Neuroscience
Publisher: Frontiers Media SA
Published: 2016-11-10
Volume: 8
Pages: 256-256
ISSN: 1663-4365 (ISSN-L)
DOI: 10.3389/fnagi.2016.00256
PMC: PMC5105117
OpenAlex: W2549210709
Semantic Scholar: 7a1f1dc8208ef2c3d7013ce699ff50704195c24d
Cited by: 946
References: 60
Citations by year: 2026: 75 · 2025: 111 · 2024: 120 · 2023: 136 · 2022: 139 · 2021: 119 · 2020: 94 · 2019: 87 · 2018: 44 · 2017: 19
FWCI: 63.01
Type: journal article
Language: en
Update notices: expression_of_concern (2020-10-07)
Open access: gold
doi.org
Licence: cc-by
Locations: Frontiers in Aging Neuroscience (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders: Kashan University of Medical Sciences
Topics: Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: Alzheimer's disease, probiotics, probiotic milk, cognitive function, metabolic status, Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum, Lactobacillus fermentum, malondialdehyde, oxidative stress, C-reactive protein, insulin resistance, beta-cell function, triglycerides, Mini-Mental State Examination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial

Abstract

Overview

AI snapshot

TL;DR

Key findings

Methods

Limitations

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks